Effects of HC antibody in autologous tum
β
Paul F. Mansfield; Marie A. Salmeron; Michael G. Rosenblum; Kyogo Itoh
π
Article
π
1991
π
John Wiley and Sons
π
French
β 689 KB
## Abstract Heteroconjugate (HC) antibody has a potential use in cancer biotherapy because of its ability to mimic antigenic specificity and induce cytotoxicity in the activated lymphocytes against various tumor cells. This study investigated the effects of HC antibody (antiβCD3 MAb x antiβp97 mela